key: cord-0980835-y9pma3z6
authors: Goff, Debra A.; Gauthier, Timothy P.; Langford, Bradley J.; Prusakov, Pavel; Ubaka Chukwuemka, Michael; Nwomeh, Benedict C.; Yunis, Khalid A.; Saad, Therese; van den Bergh, Dena; Villegas, Maria Virginia; Martinez, Nela; Morris, Andrew; Ashiru‐Oredope, Diane; Howard, Philip; Sanchez, Pablo J.
title: Global resilience and new strategies needed for antimicrobial stewardship during the COVID‐19 pandemic and beyond
date: 2022-04-17
journal: J Am Coll Clin Pharm
DOI: 10.1002/jac5.1622
sha: 0aab490e759c1921bbf64a4477352bd993fa19b0
doc_id: 980835
cord_uid: y9pma3z6

Resilience is having the ability to respond to adversity proactively and resourcefully. The coronavirus disease 2019 (COVID‐19) pandemic's profound impact on antimicrobial stewardship programs (ASP) requires clinicians to call on their own resilience to manage the demands of the pandemic and the disruption of ASP activities. This article provides examples of ASP resilience from pharmacists and physicians from seven countries with different resources and approaches to ASP—The United States, The United Kingdom, Canada, Nigeria, Lebanon, South Africa, and Colombia. The lessons learned pertain to providing ASP clinical services in the context of a global pandemic, developing new ASP paradigms in the face of COVID‐19, leveraging technology to extend the reach of ASP, and conducting international collaborative ASP research remotely. This article serves as an example of how resilience and global collaboration is sustaining our ASPs by sharing new “how to” do antimicrobial stewardship practices during the COVID‐19 pandemic.

extend the reach of ASP, and conducting international collaborative ASP research remotely. This article serves as an example of how resilience and global collaboration is sustaining our ASPs by sharing new "how to" do antimicrobial stewardship practices during the COVID-19 pandemic. The negative global impact of COVID-19 on AMR, antimicrobial stewardship programs (ASP), and antimicrobial stewards is emerging.

In the United States, health care-associated infections increased 47% in 2020 compared with 2019. 1 Multiple countries in the Americas are reporting surges in detection of drug-resistant infections. 2 A meta-analysis of 154 international studies showed that 64% of COVID-19 patients received antibiotics while the rate of proven bacterial infections was only around 8.6%. 3 Substantial and persistent disruptions to childhood vaccinations have occurred. 4 ASP pharmacists from nine high-income countries (HIC) and low-middle income countries (LMIC) reported their resources were diverted to support labor-intensive commitments related to Efforts to mitigate these problems require resilience to resourcefully reengage ASP initiatives.

The 2022 Global Research on Antimicrobial Resistance (GRAM) report estimates 4.95 million deaths associated with bacterial AMR in 2019, including at least 1.27 million deaths attributable to bacterial AMR. 6 ASPs are sub-optimal in Nigeria and this contributes to AMR. 12 A 2019 survey on the status of ASP in Nigeria revealed only 24% of tertiary hospitals have an ASP, only 6% monitor antimicrobial use, and only two had antibiograms. 13 The most common barriers to pharmacists' involvement in ASP were lack of education and training in ASP and infectious diseases. 14 Nigerian physicians recognize AMR as a problem but only 28% had heard of ASPs. 12 Hospitals routinely experience antibiotic shortages and this was exacerbated during the pandemic. Physicians often must instruct their patients to purchase antibiotics from local pharmacies and bring the supply to the hospital.

Tracking accurate hospital antibiotic use in this scenario is almost impossible. COVID-19 has diverted much attention away from ASP in the Nigerian National Action Plan for AMR. Colombian infectious diseases physicians developed diagnostic and treatment protocols for COVID-19 with pharmacists in charge of following those protocols, as well as monitoring for drug interactions US pharmacists and physicians contributed to COVID-19 local guidelines and real-time guidelines by the IDSA 8 and the NIH. 9 The CDC hosted weekly multidisciplinary Zoom meetings to allow for realtime interactive sharing of COVID-19 best practices

Shortages of hand sanitizer UK pharmacy teams learned how to locally produce WHO-formula alcohol hand rub from colleagues in Zambia, and were able to locally produce alcohol hand rubs in their hospitals when the United Kingdom became a resource-limited setting for alcohol hand rub at the start of the COVID-19 pandemic

Pharmacists in SA and Nigeria augmented the local production of high-quality hand sanitizers in the face of illegal large-scale production of substandard products by unapproved vendors 5 

There are national requirements for AMS built into all health care provider contracts with leadership at a national level and organizational delivery against contractual requirements and performance monitoring. In addition, England recently appointed seven posts to lead on regional (population: 8 million) quality improvement and performance delivery that tailors local needs to national drivers. 27 Improvements to open access data on prescribing and AMR also support identifying opportunities remotely for ASP improvement. 28 

New local efforts by pharmacists, physicians, and microbiologists at the University of Nigeria Teaching Hospital are addressing ASP practices amidst increased utilization of antimicrobials by the public during the pandemic. 30 Nigeria is particularly vulnerable to disruptions in global supply chains because about 70% of the drug supply is imported. 31 During the pandemic, pharmacists play an integral role in securing medications during drug shortages. 32

At the start of the pandemic, all ASP activities at AUBMC fixated on mitigation strategies to control COVID-19. Simultaneously, Lebanon was struggling to overcome unprecedented economic and financial crisis and political unrest, in addition to a massive blast in August 2020 that destroyed half of Beirut, damaged major hospitals, and left more than half a million citizens injured physically, economically, and psychologically. 33, 34 The health care sector is on the verge of a complete collapse due to the increase in population poverty and massive shortages in the workforce, diagnostics, medical supplies, and medications, increasing the risk for AMR. 35 Because the public resilience response is focused on strengthening the primary health care network to build long-term social solidarity, 35 the ASP at AUBMC is expanding

ASPs to the national level using the Train the Trainer pharmacist model. 36 While challenges have occurred with this ASP project within the current national crisis and the dire economic situation, the health care providers at the six participating hospitals show resilience and determination to implement ASPs. 

Although COVID-19 diverted resources and attention away from AMR and ASP in Canada, including the development and release of a National Action Plan on AMR as part of the COVID-19 response, new frameworks and connections have been established that can help to address AMR moving forward. In several of Canada's provinces, interdisciplinary clinical practice guideline working groups were formed to develop evidence-based recommendations to improve the safe, effective, and equitable use of COVID-19 pharmacotherapy. 37 Given the concern for bacterial co-infection in patients with COVID-19, appropriate empiric antibiotic use recommendations were also developed to reduce the unnecessary use of antibiotics in these patients. 37 The Canadian Institutes for Health Research provided funding for COVID research, including the support of randomized clinical trials such as SOLIDARITY. 38 The existing infrastructure and new relation- 

A UK-wide survey showed that COVID-19 had a significant negative impact on local ASP activities that included auditing antimicrobials, quality improvement initiatives, education, ASP meetings, and multidisciplinary ward rounds. 41 

In a survey of ASP leaders at 51 US hospitals, stewards reported additional duties related to COVID-19, fewer resources, more work hours, decreased ability to carry out ASP initiatives, and more symptoms of burnout than before the pandemic. 44 One ASP spent over 300 hours on 85 updates of COVID-19 guidelines in 2020. 45 Only 50% have a functional mechanism to prioritize, cost, implement, and monitor AMR national action plans. 50 The survey highlights the urgent need to build capacity to ensure the effective functioning of ASPs worldwide. In addition, there is a new WHO "Call to Action on AMR-2021" to raise global ambition on AMR. 51 It calls for enhanced national and global efforts to tackle AMR, for the acceleration of previous commitments to tackle AMR, and for improved ASP. As of 20

September 2021, there are 113 Member State signatories to the Call to Action. While the intent is good, will it be followed by meaningful action? Without ASP funding from the governments responsible for executing the national action plans, the implementation of effective ASP interventions is left to enthusiastic individuals or groups who look at the glass as half full.

As the world enters the third calendar year of the pandemic, there is deep concern for the burnout rate of pharmacists and physicians co-leading ASPs, waning political will for AMR, and appallingly low levels of ASP funding. Antimicrobial 

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network

Americas Report Surge in Drug-Resistant Infections due to Misuse of Antimicrobials During Pandemic

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study

Global contributions of pharmacists during the COVID-19 pandemic

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Choosing Wisely Canada Toolkit: The Cold Standard -Third Edition

IDSA Guidelines on the Treatment and Management of Patients with COVID-19

COVID-19) Treatment Guidelines

UK and Nigeria launch £10m partnership to tackle growing threat of drug resistance

Tackling antimicrobial resistance in the COVID-19 pandemic

Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs

Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: findings and implications

Nationwide survey of pharmacists' involvement in antimicrobial stewardship programs in Nigerian tertiary hospitals

Lebanon: Lebanese Ministry of Public Health

A systematic review of Antimicrobial Stewardship Program implementation in Middle Eastern countries

Effect of a "handshake" stewardship program versus a formulary restriction policy on high-end antibiotic use, expenditure, antibiotic resistance, and patient outcome

Plan Nacional De Respuesta A Los Antimicrobianos

Antimicrobial stewardship across 47 South African hospitals: an implementation study

A pharmacist-led prospective antibiotic stewardship intervention improves compliance to community-acquired pneumonia guidelines in 39 public and private hospitals across South Africa

National Neonatal Sepsis Task Force launch: Supporting infection prevention and surveillance, outbreak investigation and antimicrobial stewardship in neonatal units in South Africa

Core Elements of Hospital Antibiotic Stewardship Programs

International train the trainer antibiotic stewardship program for pharmacists: implementation, sustainability, and outcomes

Virtual learning collaboratives to improve urine culturing and antibiotic prescribing in long-term care: controlled before-and-after study

Choosing Wisely Canada" and antimicrobial stewardship: A shared focus on reducing unnecessary care

Meet the New Antimicrobial Prescribing Optimisation Team

Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips

Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey

Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: A population-based survey in Nigeria

Drug supply shortage in Nigeria during COVID-19: efforts and challenges

Global drug shortages due to COVID-19: impact on patient care and mitigation strategies

COVID-19 pandemic: an insult over injury for Lebanon

COVID-19 pandemic in Lebanon: One year later, what have we learnt? mSystems

Shortage of appropriate diagnostics for antimicrobial resistance in Lebanese clinical settings: a crisis amplified by COVID-19 and economic collapse

International train the trainer neonatal antibiotic stewardship program for South African pharmacists

COVID-19 Advisory for Ontario Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

WHO COVID-19 Solidarity Therapeutics Trial

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression

Assessing the impact of COVID-19 on antimicrobial stewardship activities/programs in the United Kingdom

I'm at breaking point"; Exploring pharmacists' resilience, coping and burnout during the COVID-19 pandemic

Clinical Innovations During COVID-19

Duties, resources, and burnout of antibiotic stewards during the coronavirus disease 2019 (COVID-19) pandemic

COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications

Sharing antimicrobial reports for pediatric stewardship (SHARPS): a quality improvement collaborative

The future of antibiotic stewardshipmanaging access and excess

Antimicrobial resistance research in a post-pandemic world: insights on antimicrobial resistance research in the COVID-19 pandemic

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail

More Countries Committing to Tackling Antimicrobial Resistance

Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond